S&P 500 Futures
(0.41%) 5 112.50 points
Dow Jones Futures
(0.84%) 38 704 points
Nasdaq Futures
(0.69%) 17 772 points
Oil
(0.20%) $79.11
Gas
(0.00%) $2.04
Gold
(-0.04%) $2 308.60
Silver
(-0.20%) $26.78
Platinum
(1.70%) $979.00
USD/EUR
(-0.14%) $0.931
USD/NOK
(-0.69%) $10.92
USD/GBP
(-0.18%) $0.796
USD/RUB
(0.46%) $91.55

实时更新: Till Capital Ltd. [TIL]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间3 May 2024 @ 04:00

4.66% $ 11.22

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 04:00):
Profile picture for Till Capital Ltd.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL)...

Stats
今日成交量 3 615.00
平均成交量 14 170.00
市值 72.97M
EPS $0 ( 2024-03-29 )
下一个收益日期 ( $-2.16 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.470
ATR14 $0.0680 (0.61%)
Insider Trading
Date Person Action Amount type
2024-02-10 Laumas Sandeep Buy 80 000 Employee Stock Option (right to buy)
2024-02-10 Crouch Bronson Buy 120 000 Employee Stock Option (right to buy)
2023-06-14 Binder Gwendolyn Buy 1 500 Stock Option (Right to Buy)
2023-06-14 Mcgaughy R Kent Jr Buy 1 500 Stock Option (Right to Buy)
2023-06-14 Gibson Neil W Buy 1 500 Stock Option (Right to Buy)
INSIDER POWER
97.91
Last 92 transactions
Buy: 125 955 560 | Sell: 140 779 900

Till Capital Ltd. 相关性

10 最正相关
SLNH0.963
AVCT0.951
TFFP0.945
MRACW0.941
NRBO0.936
ULBI0.93
WISA0.93
ONCS0.927
RMRM0.923
TOI0.923
10 最负相关
VLYPO-0.949
IART-0.933
MDLZ-0.926
PPH-0.92
SLGN-0.918
MNST-0.918
NRIM-0.912
KLAC-0.91
RFEU-0.907
ROST-0.903

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Till Capital Ltd. 财务报表

Annual 2023
营收: $0
毛利润: $-4.76M (0.00 %)
EPS: $-24.00
FY 2023
营收: $0
毛利润: $-4.76M (0.00 %)
EPS: $-24.00
FY 2022
营收: $0
毛利润: $-5.99M (0.00 %)
EPS: $-34.46
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $0

Financial Reports:

No articles found.

Till Capital Ltd.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。